Prostatic Neoplasms Completed Phase 3 Trials for Cabazitaxel (DB06772)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00417079XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerTreatment